What is X2 Biosystems?
X2 Biosystems focuses on the Integrated Concussion Evaluation (ICE) Application, a mobile platform designed for athlete concussion assessments that adheres to the standardized Sports Concussion Assessment Tool (SCAT). The ICE App enhances collaboration among athletic trainers, team physicians, and healthcare providers by enabling real-time communication and facilitating neurocognitive baseline testing alongside post-impact assessments. This HIPAA-compliant software ensures the secure handling of sensitive athlete data, allowing for swift and precise diagnoses. Its customizable exam templates further support comprehensive data capture, positioning X2 Biosystems as a key player in sports health technology.
How much funding has X2 Biosystems raised?
X2 Biosystems has raised a total of $10.2M across 4 funding rounds:
Debt
$2M
Unspecified
$3.3M
Debt
$720K
Debt
$4.2M
Debt (2010): $2M, investors not publicly disclosed
Unspecified (2012): $3.3M, investors not publicly disclosed
Debt (2013): $720K, investors not publicly disclosed
Debt (2014): $4.2M, investors not publicly disclosed
What's next for X2 Biosystems?
The substantial enterprise-level funding and recent strategic investment indicate a strong market validation for X2 Biosystems' concussion assessment solutions. This capital infusion is likely to fuel further product development, enhance market penetration, and potentially expand the company's reach into new athletic leagues and healthcare systems. The focus on secure, collaborative, and standardized assessment tools suggests a strategic push towards becoming an industry standard in sports concussion management, with future growth potentially involving partnerships with major sports organizations and healthcare providers.
See full X2 Biosystems company page
